1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease : An open-label prospective observational study of effectiveness, tolerability and healthcare costs
(
- Contribution to journal › Article
- 2014
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo (R) (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess (R)/Comtan (R) (Entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment
(
- Contribution to journal › Article
- 1999
-
Mark
Dyskinesias assessment : From CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies
(
- Contribution to journal › Article
- 1994
-
Mark
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
(
- Contribution to journal › Article
- 1993
-
Mark
Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism
(
- Contribution to journal › Article
- 1992
-
Mark
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : one-year clinical and neurophysiological observations in two patients with putaminal implants
(
- Contribution to journal › Article
-
Mark
Core assessment program for intracerebral transplantations (CAPIT)
(
- Contribution to journal › Article
- 1989
-
Mark
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
(
- Contribution to journal › Article